Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection
Serologic assays have become increasingly available for surveillance through the Food and Drug Administration emergency use authorization in the ongoi...
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses
In December 2019, the first COVID-19 case, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China.
False negative rate of COVID-19 PCR testing: a discordant testing analysis
COVID-19 is diagnosed via detection of SARS-CoV-2 RNA using real time reverse-transcriptase polymerase chain reaction (rtRT-PCR) Performance of many S...
Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia
Since COVID-19 pandemic is a global crisis, tests with high sensitivity and specificity are crucial for the identification and management of COVIid-19...
Diagnosis of COVID-19 Based on Symptomatic Analysis of Hospital Healthcare Workers in Belgium: Observational Study in a Large Belgian Tertiary Care Center During Early COVID-19 Outbreak
Cough (82%), headache (78%), myalgia (70%), loss of smell or taste (40%) and fever more than or equal to 37.5 °C (76%) were significantly higher among...
A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations
Comparative assessments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular assays are warranted to assess real-world performanc...
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers
To address this concern, universal (non-symptom-based) screening of HCWs was piloted. All participants were tested for SARS-CoV-2 using reverse transc...
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
Plasma collection began in two Brazilian hospitals for treatment of severe/critical patients. Donor's weight, days between disease onset and serial pl...